In Vitro Transcriptional and Translational Block of the bcl-2 Gene Operated by Peptide Nucleic Acid
- 22 October 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 264 (2), 537-543
- https://doi.org/10.1006/bbrc.1999.1548
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Promise and Problems of Bcl-2 Antisense TherapyJNCI Journal of the National Cancer Institute, 1997
- The proto-oncogene Bcl-2 and its role in regulating apoptosisNature Medicine, 1997
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- Progress in Antisense Oligonucleotide TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurrent Opinion in Oncology, 1995
- Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cellsBlood, 1994
- Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction ofbcl-2 Gene ExpressionAntisense Research and Development, 1994
- PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rulesNature, 1993
- Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted PolyamideScience, 1991
- Involvement of the bcl -2 Gene in Human Follicular LymphomaScience, 1985